Funding and Finance: Page 2

Labcorp to acquire MAWD Pathology Group assets

By LabPulse.com staff writers

Labcorp has agreed to acquire select assets of MAWD Pathology Group's clinical and women's health testing businesses.

December 16, 2024

$16.5B Novo, Catalent deal moves forward without FTC challenge

By LabPulse.com staff writers

U.S.-based Catalent and its suitor Denmark-based Novo Holdings have fulfilled all regulatory closing conditions for their pending $16.5 billion transaction.

December 16, 2024

Pleno closes $25M series B funding round, names new CEO

By LabPulse.com staff writers

Multiomics firm Pleno has closed a $25 million series B funding round and appointed a new CEO.

December 12, 2024

Biomemory raises $18M in series A funding

By LabPulse.com staff writers

DNA data storage firm Biomemory announced that it has raised $18 million in series A funding.

December 10, 2024

T2 Biosystems to license pathogen-detection technology

By LabPulse.com staff writers

T2 Biosystems plans to license its proprietary technology for the detection of sepsis-causing pathogens from whole blood.

December 9, 2024

Amgen to open second N.C. manufacturing facility

By LabPulse.com staff writers

Biotech firm and drug manufacturer Amgen has announced a $1 billion expansion in North Carolina, with plans to establish a second manufacturing facility in the state.

December 6, 2024

COUR Pharmaceuticals, Genentech sign agreement on autoimmune therapeutics development

By LabPulse.com staff writers

Clinical-stage biotech firm COUR Pharmaceuticals announced a strategic partnership and licensing agreement with Genentech for the development and commercialization of COUR's nanoparticle treatments for an undisclosed autoimmune disorder.

December 3, 2024

Kronos Bio announces layoffs, CEO transition

By LabPulse.com staff writers

Kronos Bio will lay off approximately 83% of its workforce as part of a previously announced cost-reduction strategy.

December 2, 2024

Jury awards Guardant nearly $293M in lawsuit against Natera

By LabPulse.com staff writers

A federal jury in the U.S. District Court for the Northern District of California ruled in favor of Guardant Health in a lawsuit the company filed against Natera in May 2021.

November 26, 2024

Vyriad, Novartis to collaborate on CAR-T cell therapies

By LabPulse.com staff writers

Clinical-stage biotech firm Vyriad has entered into a strategic partnership with Novartis to discover and develop chimeric antigen receptor (CAR) T-cell therapies.

November 22, 2024

Precision for Medicine partners with Agena Bioscience to fill NGS testing gaps

By LabPulse.com staff writers

Partnership addresses insufficient sample quality in next-generation sequencing (NGS) testing.

November 20, 2024

Texas lab owner accused of $79M RPP fraud scheme

By LabPulse.com staff writers

The DOJ implicated a Texas clinical laboratory owner and operator in respiratory pathogen panel testing fraud scheme.

November 25, 2024

Previous Page

Page 2 of 144

Next Page